Johnson & Johnson vaccine benefits ‘far outweigh’ risks: CDC
About 100 preliminary reports of Guillain-Barre syndrome have been detected in vaccine recipients after the administration of 12.8 million doses of the Johnson & Johnson vaccine in the US, according to the FDA
